Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A0832 - Delayed partial nephrectomy following complete response to immunotherapy: Feasibility and results (UroCCR n°157)

Autor: Margue, G., Parier, B., Albiges, L., Klein, C., Pignot, G., Gravis, G., Bigot, P., Baize, N., Ingels, A., Charlotte, J., Audenet, F., Vano, Y., Waeckel, T., Levard, R., Gross-Goupil, M., Bernhard, J.C.

Publikováno v: In European Urology March 2024 85 Supplement 1:S1848-S1849

Problématiques actuelles et perspectives du ganglion sentinelle dans le mélanome, à l’ère de la non-réalisation systématique de celui-ci : une étude multicentrique à partir de la base de données RICMEL

Autor: Deriouich, M., Levard, R., Tagmouti, T., Sanogo, D., Cassecuel, J., Khammari, A., Quéreux, G., Dompmartin, A., Dreno, B., L’orphelin, J.M.

Publikováno v: Annales de Dermatologie et de Vénéréologie - FMC; December 2024, Vol. 4 Issue: 8, Number 8 Supplement 1 pA96-A96, 1p

Delayed partial nephrectomy following complete response to immunotherapy: feasibility and results (UroCCR n°157).

Autor: Margue G; Bordeaux University Hospital, Urology department, Bordeaux, France; Kidney Cancer group of the French Association of Urology Cancer Committee, Paris, France. Electronic address: gaelle.margue@chu-bordeaux.fr., Klein C; Bordeaux University Hospital, Urology department, Bordeaux, France., Parier B; Kremlin-Bicêtre -APHP, Urology department, Paris, France., Albiges L; Kidney Cancer group of the French Association of Urology Cancer Committee, Paris, France; Gustave Roussy Institute, Medical oncology department, Paris, France., Pignot G; Paoli Calmette Institute, Urology department, Marseille, France., Gravis G; Paoli Calmette Institute, Medical oncology department, Marseille, France., Bigot P; Kidney Cancer group of the French Association of Urology Cancer Committee, Paris, France; Angers University Hospital, Urology department, Angers, France., Baize N; Angers University Hospital, Medical oncology department, Angers, France., Ingels A; Kidney Cancer group of the French Association of Urology Cancer Committee, Paris, France; Henri Mondor hospital-APHP, Urology department, Paris, France., Joly C; Henri Mondor hospital-APHP, Medical oncology department, Paris, France., Audenet F; HEGP-APHP, Urology department, Paris, France., Vano Y; HEGP-APHP, Medical oncology department, Paris, France., Waeckel T; Kidney Cancer group of the French Association of Urology Cancer Committee, Paris, France; Caen University Hospital, Urology department, Caen, France., Levard R; Caen University Hospital, Medical oncology department, Caen, France., Barthelemy P; Kidney Cancer group of the French Association of Urology Cancer Committee, Paris, France; ICANS, Medical oncology department, Strasbourg, France., Ambrosetti D; Nice University Hospital, Pathology department, Nice, France., Verkarre V; HEGP-APHP, Pathology department, Paris, France., Yacoub M; Bordeaux University Hospital, Pathology department, Bordeaux, France., Gross-Goupil M; Bordeaux University Hospital, Medical oncology department, Bordeaux, France., Bernhard JC; Bordeaux University Hospital, Urology department, Bordeaux, France; Kidney Cancer group of the French Association of Urology Cancer Committee, Paris, France.

Publikováno v: Urologic oncology [Urol Oncol] 2024 Nov 26. Date of Electronic Publication: 2024 Nov 26.